cjc 1295 combined with ipamorelin CJC-1295 Blend 5MG CJC-1295 (NO DAC) + IPAMORELIN

CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days

Medical screening is essential to ensure safety and efficacy

This peptide supports muscle growth, accelerates recovery, and aids in reducing body fat, making it effective for improving body composition

Formulation vehicle: Lipid-based vehicles outperform water-based serums for absorption

Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I